gadolinium dtpa has been researched along with Esophageal Squamous Cell Carcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Ge, XL; Liu, XS; Sun, NN; Xu, LL | 1 |
Ge, X; Liu, X; Sun, N; Xu, L | 1 |
Hou, J; Li, FP; Lu, Q; Tang, J; Wang, H; Wang, LL; Yu, XP | 1 |
3 other study(ies) available for gadolinium dtpa and Esophageal Squamous Cell Carcinoma
Article | Year |
---|---|
Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Contrast Media; Esophageal Squamous Cell Carcinoma; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Retrospective Studies | 2020 |
Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
Topics: Aged; Chemoradiotherapy; Contrast Media; Esophageal Squamous Cell Carcinoma; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Neoplasm Staging; Progression-Free Survival; Radiotherapy Dosage; Retrospective Studies | 2020 |
Utility of intravoxel incoherent motion diffusion-weighted imaging in predicting early response to concurrent chemoradiotherapy in oesophageal squamous cell carcinoma.
Topics: Chemoradiotherapy; Contrast Media; Diffusion Magnetic Resonance Imaging; Esophageal Squamous Cell Carcinoma; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Predictive Value of Tests; Treatment Outcome | 2018 |